Guidelines on the administration of gadolinium Based Contrast Agents (GBCAs) have for a long time now recommended that the lowest dose possible be used that is compatible with the acquistion of diagnostically useful images. DIEurope spoke to Dr Martin Rosenberg, Executive Director, Medical & Clinical Affairs Radiology, Bayer
Read More here: MRI reduced-dose Dr Rosenberg Bayer DIEurope December 2021